Nonregional Lymph Nodes as the Only Metastatic Site in Stage IV Esophageal Cancer
Introduction: Metastatic involvement of at least one nonregional lymph node currently renders patients with esophageal cancer as having stage IV disease. However, the management and outcomes of patients whose sole determinant of stage IV status is nonregional lymph nodes (abbreviated as “stage IV-no...
Main Authors: | Peter L. Zhan, MD, Maureen E. Canavan, PhD, MPH, Theresa Ermer, MD, Matthew D. Pichert, MD, MPH, Andrew X. Li, MD, Richard C. Maduka, MD, Michael F. Kaminski, BA, Daniel J. Boffa, MD, MBA |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-12-01
|
Series: | JTO Clinical and Research Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666364322001503 |
Similar Items
-
Utilization and Outcomes of Radiation in Stage IV Esophageal Cancer
by: Peter Lee Zhan, MD, et al.
Published: (2022-12-01) -
Clinical TNM staging for esophageal, gastric, and colorectal cancers in the era of neoadjuvant therapy: A systematic review of the literature
by: Hideaki Shimada, et al.
Published: (2021-07-01) -
Distribution of Lymph Node Metastases in Esophageal Carcinoma Patients Undergoing Upfront Surgery: A Systematic Review
by: Eliza R. C. Hagens, et al.
Published: (2020-06-01) -
Nomograms for predicting risk of locoregional recurrence and distant metastases for esophageal cancer patients after radical esophagectomy
by: Wen-Yi Zhang, et al.
Published: (2018-09-01) -
Retropharyngeal Lymph Node Involvement in Oropharyngeal Carcinoma: Impact upon Risk of Distant Metastases and Survival Outcomes
by: Zsuzsanna Iyizoba-Ebozue, et al.
Published: (2019-12-01)